- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Here's how to trade seven of the most active stocks on the market this week.
Bristol-Myers Squibb suffers a setback in immunotherapy treatment for newly diagnosed lung cancer.
Bristol-Myers suffered another setback when the pharma giant said it would not seek accelerated approval for a combination of two immunotherapy drugs as a treatment for newly diagnosed lung cancer.
Don't worry about a little selloff, says Jim Cramer. The data and earnings signal an improving economy.